Belarus vs Monaco: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Belarus
16.0%
in 2025
Monaco
0.0%
in 2025
Belarus rank
165th
Monaco rank
167th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Belarus
- Monaco
How they compare
Belarus currently reports 16.0% against 0.0% in Monaco, a difference of 16.0%.
The two have swapped places 1 time across 18 shared years of data; in 2008 it was Monaco ahead.
Belarus ranks 165th and Monaco ranks 167th of 194 countries.
Belarus has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Belarus | Monaco | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 0.0% | 0.0% | 0.0% | — |
| 2020s | 2.7% | 0.0% | 2.7% | Belarus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Belarus or Monaco?
- Belarus, at 16.0% against 0.0% in Monaco as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Belarus and Monaco?
- 16.0%, with Belarus ahead.
- How many years of comparable data are there for Belarus and Monaco?
- 18 years are reported by both, from 2008 to 2025.
- How do Belarus and Monaco rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Belarus ranks 165th and Monaco ranks 167th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.